PepGen (PEPG) Change in Account Payables (2021 - 2026)
PepGen (PEPG) reported Change in Account Payables of -$183000.0 for Q1 2026, down 119.41% on a YoY basis from $943000.0 in Q1 2025, and down 608.33% sequentially from $36000.0 in Q4 2025.
PepGen (PEPG) Change in Account Payables (2021 - 2026) Analysis & Trends
PepGen (PEPG) has 6 years of Change in Account Payables data on file, last reported at -$183000.0 in Q1 2026.
- For the quarter ending Q1 2026, Change in Account Payables fell 119.41% year-over-year to -$183000.0; the trailing twelve-month figure through Mar 2026 stood at -$2.1 million (down 230.69% YoY), and the FY2025 full-year result was -$935000.0, down 229.5% from the prior year.
- Change in Account Payables retreated to -$183000.0 in Q1 2026, from $36000.0 in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $6.5 million in Q2 2024 to a low of -$4.2 million in Q4 2024.
- A 5-year average of -$127764.7 and a median of -$86000.0 in 2025 frame the typical range for Change in Account Payables.
- Across the five-year window, Change in Account Payables plunged 3919.05% in 2022 and surged 1440.76% in 2024, its largest moves.
- Tracing PEPG's Change in Account Payables over 5 years: stood at -$3.2 million in 2022, then advanced by 9.46% to -$2.9 million in 2023, then tumbled by 43.14% to -$4.2 million in 2024, then soared by 100.86% to $36000.0 in 2025, then plunged by 608.33% to -$183000.0 in 2026.
- Business Quant data shows PEPG's Change in Account Payables at -$183000.0 in Q1 2026, $36000.0 in Q4 2025, and -$86000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -42.19 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.52 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 35.60 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.86 Mn |
| 10 | PepGen | 145.09 Mn | 145.09 Mn | - | -183,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -183,000.00 |
| Mar 31, 2026 | -183,000.00 |
| Dec 31, 2025 | 36,000.00 |
| Dec 31, 2025 | 36,000.00 |
| Sep 30, 2025 | -86,000.00 |
| Sep 30, 2025 | -86,000.00 |
| Jun 30, 2025 | -1.83 Mn |
| Jun 30, 2025 | -1.83 Mn |
| Mar 31, 2025 | 943,000.00 |
| Mar 31, 2025 | 943,000.00 |
| Dec 31, 2024 | -4.19 Mn |
| Dec 31, 2024 | -4.19 Mn |
| Sep 30, 2024 | -1.67 Mn |
| Sep 30, 2024 | -1.67 Mn |
| Jun 30, 2024 | 6.50 Mn |
| Jun 30, 2024 | 6.50 Mn |
| Mar 31, 2024 | 88,000.00 |
| Mar 31, 2024 | 88,000.00 |
| Dec 31, 2023 | -2.93 Mn |
| Dec 31, 2023 | -2.93 Mn |